Used as a key chiral intermediate in the synthesis of biologically active compounds, particularly in pharmaceuticals targeting central nervous system disorders. Its fluorinated structure enhances metabolic stability and bioavailability, making it valuable in developing selective serotonin reuptake inhibitors (SSRIs) and related antidepressant drugs. The compound’s stereochemistry allows for precise interaction with enzymatic targets, improving drug efficacy and reducing side effects. Commonly employed in asymmetric synthesis routes where high enantiomeric purity is required for optimal therapeutic performance.